Patient demographics and clinical outcomes among type 1 diabetes (T1D) patients using Continuous Glucose Monitors (CGMs): real world evidence from a large U.S. collaborative.
CGM devices have been shown to improve glycemic control in patients with T1D. Despite existing clinical evidence and improved performance…
T1D Exchange at ISPAD 2020 Virtual Annual Conference
T1D Exchange to Highlight Quality Improvement Data at ISPAD 2020 Virtual Annual Conference In keeping with its mission to advance…
Multi-site quality improvement project: improving Continuous Glucose Monitor (CGM) uptake across ten U.S Centers.
Introduction: The T1DX-QI is a national Type 1 diabetes learning health system with thirteen endocrinology centers. The program is coordinated by…
Race/Ethnicity Disparities of presenting symptoms and outcomes among patients with type 1 diabetes with confirmed or suspected COVID-19 in the United States.
Introduction: While there is rapidly emerging information describing race or ethnicity outcome disparities of patients hospitalized with COVID-19, no such data…
Improving care for high-risk patients: lessons from the T1D Exchange Quality Improvement Collaborative (T1DX-QI).
Introduction: The T1DX-QI is a Type 1 diabetes learning health system with thirteen endocrinology centers working collaboratively on the goal of…
A population health data platform to improve outcomes in the T1D Exchange Quality Improvement Collaborative (T1DX-QI).
A multidisciplinary group designed the T1DX-QI to improve type 1 diabetes (T1D) care by sharing QI tools and expertise among…
Improving diabetes care through population health studies: insights from the largest U.S population based T1D cohort.
Introduction: Population-based registries are proven tools for tracking outcomes and improving the quality of care delivery. The T1DX-QI is a population-based…
